线上药店发放牌照225张,仅40家运营

  • 线上药店,网上药品,药店牌照,八百方信息技术,互联网药品交易服务资格证
  • 新快报

“金矿”还是“沼泽”?

近日,全国第二家网上零售药品第三方平台试点企业的牌照被广州八百方信息技术有限公司(下称“八百方”)摘得。至此,中国的线上药品市场出现了阿里巴巴和“八百方”两分天下的局面。

线上药品市场到底是“金矿”还是“沼泽”?有业内人士直言,批了225家网上药店资格,但实际运作的仅40家左右。

圈地的多运营的少

记者从国家食品药品监督管理总局的官网上看到,截至7月24日下午2时,获取《互联网药品交易服务资格证》的网上药店达225家。不过,记者从业内人士了解到,目前运营的比较好的、正规的网上药店只有40家左右。

“如果一天的营业额达不到三四万元,一般的网上药店就很难生存,而大多数是达不到这个标准的。”广东金康药房连锁有限公司经理郑浩涛告诉记者,虽然已有225家网上药店摘得了药监局的网上售药的牌照,但这也不意味着这些店都在正常运营。“有些是跟风,获得一个牌照放在那里,然后一直观望。”

郑浩涛表示,随着阿里巴巴和八百方药品B2C第三方平台的拓展,越来越多的投资者会将目光投向线上药店,试图瓜分中国移动医疗市场的一杯羹。

“斗价”严重易畸形竞争

线上药店一个难以回避的问题是,以低价营销发家的网上购物模式,势必将搅乱现有的药品价格体系。从目前的天猫医药馆和京东的好药师旗舰店来看,其加盟的网上药店为做大销量,时常推出诸如“团购”、“秒杀”等价格杀手锏。

郑浩涛认为,线上药店的特点就是鼠标交易,“速度很快,只有尽量标低价格才能留住顾客”。层出不穷的“斗价”的现象,刺激线上药店之间陷入一种畸形的竞争。郑浩涛还分析,线上药店的一个暂未解决的难题是“只能卖非处方药”。

诚信制约网上药店发展

“实体药店透过互联网向个人消费者卖药,将是未来医药零售业发展的一个比较明显的趋势。”郑浩涛认为。

从资金投入来看,相对于实体药店平均近30万元一间店的开店成本,网上药店不需店面租金,人力资源成本也低,所以药品销售价格比实体药店可以更低。加上经营不受地域限制、客源更加丰富等,网上药店的优势凸显无疑。

但是,线上药店有一个“软肋”——药品的真假。有分析人士指出,网上药店目前还没有完善的诚信体系,在互联网假货泛滥的情况下,消费者本来就脆弱的信任受到伤害,网上药店显得任重而道远。

This link:http://www.chemcd.com/news/1153.html

The ChemCD compiler finishing, shall not be reproduced without permission, for reprint please indicate the source。

comments powered by Disqus

Categories

Related News

Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence.

Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sarilumab.

First data backs efficacy of BMS' novel HIV drug

A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.

EU Rules Could Restrict Genetic Testing

Genetic testing describes the application of laboratory methods to look at a person’s genes (the inherited DNA instructions). Genetic tests can be used to diagnose a genetic condition; screen for a risk of developing a particular health problems; for the selection of treatments; or to assess responses to treatments.

CHMP adopts positive opinion of Edurant in adolescents with HIV-1

The CHMP has adopted a positive opinion recommending a change to the terms of the marketing authorisation for Janssen’s Edurant (rilpivirine) in the EU to extend the indication to adolescent patients aged 12 to <18 years with human immunodeficiency virus-1 (HIV-1) infection

FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval

Neos Therapeutics got an ominous note from the FDA just weeks ahead of the expected approval date for its long-acting ADHD treatment, clouding the future of the company's lead asset.

Pfizer's once-failed cancer drug wins the FDA's 'breakthrough' tag

Pfizer has found new hope for a former pipeline standout, picking up the FDA's coveted breakthrough therapy designation for a Phase III reclamation project in oncology.